Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2005. Start Trial.
Date Value
December 31, 2025 987.74M
December 31, 2024 -134.99M
December 31, 2023 -61.76M
December 31, 2022 -133.11M
December 31, 2021 -192.62M
December 31, 2020 -105.32M
December 31, 2019 -61.25M
December 31, 2018 -72.87M
December 31, 2017 -42.27M
December 31, 2016 7.234M
December 31, 2015 -33.51M
Date Value
December 31, 2014 -7.506M
December 31, 2013 -30.19M
December 31, 2012 11.83M
December 31, 2011 -0.3371M
December 31, 2010 -9.947M
December 31, 2009 -11.48M
December 31, 2008 -5.617M
December 31, 2007 -10.58M
December 31, 2006 -15.20M
December 31, 2005 -7.591M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Genmab A/S 1.190B
Ascendis Pharma A/S 60.83M
Bavarian Nordic A/S 411.60M
Evaxion AS -6.645M
ACADIA Pharmaceuticals, Inc. 109.84M